Alkem Q2 FY27 consolidated revenue ₹4,551.99 cr; PAT ₹667.13 cr
Results$ALKEM

Alkem Q2 FY27 consolidated revenue ₹4,551.99 cr; PAT ₹667.13 cr

For Q2 FY27, Alkem’s consolidated revenue from operations rose to Rs 4,551.99 cr while profit after tax was Rs 667.13 cr versus Rs 779.11 cr a year earlier.

Alkem Laboratories Ltd
Alkem Laboratories LtdReviewed and published by · How we report
3 min read
alkem laboratoriesq2 fy27 resultspharmaearningsindia
ShareWhatsAppXLinkedIn

Key takeaways

  • Revenue from operations was Rs 4,551.99 cr vs Rs 4,000.99 cr a year earlier.
  • Total income rose to Rs 4,686.20 cr from Rs 4,104.68 cr in Q2 FY26.
  • Total expenses increased to Rs 3,721.55 cr from Rs 3,208.85 cr.
  • PAT was Rs 667.13 cr compared with Rs 779.11 cr in the prior-year quarter.
  • Basic and diluted EPS were Rs 56.48 vs Rs 63.99 in the corresponding quarter.

Q2 FY27 · consolidated

MetricSep 2026Sep 2025Change
RevenueRs 4,551.99 crRs 4,000.99 cr+13.8%
PATRs 667.13 crRs 779.11 cr-14.4%
EPSRs 56.48Rs 63.99-11.7%

As reported in the filing. Figures are transcribed, not computed.

Alkem Laboratories Ltd's next results reach Pro the minute they're filed.Try Pro free for 14 days

What the numbers show

  • Net margin was 14.66% of revenue, down 481 bps from 19.47%.

  • Total expenses rose 16.0% while revenue rose 13.8%.

  • Other expenses took 24.9% of revenue, against 24.2% a year earlier.

  • Basis: Consolidated statement of financial results for the quarter ended 30.09.2026, compared with quarter ended 30.09.2025.

  • Revenue from operations: Rs 4,551.99 cr (Q2 FY27) vs Rs 4,000.99 cr (Q2 FY26).

  • Total income: Rs 4,686.20 cr vs Rs 4,104.68 cr.

  • Total expenses: Rs 3,721.55 cr vs Rs 3,208.85 cr.

  • Cost of materials consumed: Rs 1,083.03 cr vs Rs 905.57 cr.

  • Purchases of stock-in-trade: Rs 468.83 cr vs Rs 471.57 cr.

  • Changes in inventories of finished goods, work-in-progress and stock-in-trade: Rs (57.11) cr vs Rs 23.89 cr.

  • Employee benefits expense: Rs 896.52 cr vs Rs 710.25 cr.

  • Finance costs: Rs 57.67 cr vs Rs 35.02 cr.

  • Depreciation and amortisation expense: Rs 137.08 cr vs Rs 93.61 cr.

  • Other expenses: Rs 1,135.53 cr vs Rs 968.94 cr.

  • Profit before exceptional items and tax: Rs 964.65 cr vs Rs 895.83 cr.

  • Exceptional items: Rs 35.00 cr vs Rs - .

  • Profit before tax: Rs 999.65 cr vs Rs 895.83 cr.

  • Profit for the period (PAT): Rs 667.13 cr vs Rs 779.11 cr.

  • Earnings per share – Basic: Rs 56.48 vs Rs 63.99.

  • Earnings per share – Diluted: Rs 56.48 vs Rs 63.99.

For the quarter ended 30.09.2026, consolidated revenue from operations reported in the statement of financial results increased to Rs 4,551.99 cr from Rs 4,000.99 cr in the corresponding quarter ended 30.09.2025. Total income, which includes other income, moved to Rs 4,686.20 cr from Rs 4,104.68 cr over the same period.

On the cost side, total expenses rose to Rs 3,721.55 cr from Rs 3,208.85 cr. Within this, cost of materials consumed increased to Rs 1,083.03 cr from Rs 905.57 cr, while purchases of stock-in-trade were Rs 468.83 cr compared with Rs 471.57 cr. The line for changes in inventories of finished goods, work-in-progress and stock-in-trade showed Rs (57.11) cr against Rs 23.89 cr a year earlier. Employee benefits expense rose to Rs 896.52 cr from Rs 710.25 cr. Finance costs were Rs 57.67 cr versus Rs 35.02 cr, and depreciation and amortisation expense increased to Rs 137.08 cr from Rs 93.61 cr. Other expenses stood at Rs 1,135.53 cr compared with Rs 968.94 cr.

Profit before exceptional items and tax was Rs 964.65 cr for Q2 FY27, up from Rs 895.83 cr in Q2 FY26. The statement of financial results shows an exceptional item of Rs 35.00 cr in the current quarter, with no exceptional item reported in the corresponding prior quarter, taking profit before tax to Rs 999.65 cr versus Rs 895.83 cr.

After total tax expense of Rs 331.91 cr (vs Rs 116.23 cr) and share in loss after tax of associate of Rs (0.61) cr (vs Rs (0.49) cr), profit for the period was Rs 667.13 cr compared with Rs 779.11 cr a year earlier. Basic and diluted earnings per share for the quarter were both Rs 56.48, down from Rs 63.99 in the corresponding quarter, as per the statement of financial results.

Get Alkem Laboratories Ltd's next results the minute they're filed

Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.

  • We'll start you off following ALKEM.
  • 14 days free, no card. After that you keep a free account.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.